澳美制药

Bright Future Pharmaceutical is a leading Hong Kong-based pharmaceutical company founded in 1993, specializing in the research, development, manufacturing, and marketing of high-quality generic medicines. The company maintains a diverse portfolio covering therapeutic areas such as dermatology, respiratory, pediatrics, and pain management, with a strong presence in both prescription and over-the-counter (OTC) markets. Operating multiple GMP-certified manufacturing facilities in Hong Kong and Mainland China, Bright Future is one of the largest pharmaceutical exporters in Hong Kong. The company is committed to providing affordable and effective healthcare solutions globally, supported by a robust R&D pipeline focused on advanced drug delivery systems and complex generics. Its products are distributed across Greater China, Southeast Asia, and Africa.